Curriculum Vitae: Ira L. Cohen, Ph.D., F.A.P.S. Professional Education 1975-77 National Institute of Mental Health Post-Doctoral Fellow, Behavior Therapy, Experimental Psychopathology, New York University Medical Center, New York, NY 1974 Ph.D., Psychobiology, Rutgers - The State University, New Brunswick, NJ 1972 M.S., Psychobiology, Rutgers - The State University 1969 B.A., Psychology, Temple University, Philadelphia, PA Other Professional Training 1999 Autism Diagnostic Observation Schedule training and certification. Training by

Catherine Lord, University of Chicago, August 2-6. 1999 Autism Diagnostic Interview training and certification. Training at IBR by Christopher Smith of Mt. Sinai Hospital, June 29-30. 1993 Advanced Neural Computing, NeuralWare, Inc., Robert Morris College, Pittsburgh, PA, December 6-8. 1992 Neural Networks: Introduction and Foundations, Wang Institute of Boston University, Tyngsboro, MA, May 9-14. Current Position 2006 - Chairman, Dept. of Psychology, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, NY 1984 - Head, Division of Behavioral Assessment & Research, Dept. of Psychology, NYS Institute for Basic Research in Developmental Disabilities, Staten Island, NY. 1981 - Research Scientist, Dept. of Psychology, NYS Institute for Basic Research in Developmental Disabilities. Areas of Research: Behavioral assessment of autistic and other developmentally disabled individuals. Fragile X and autism. Pharmacotherapy, Behavior Pathology, Diagnosis, Neural Networks, Early Intervention. Previous Research Positions 1977-81 Research Psychologist, Children's Psychopharmacology Unit, Dept. of Psychiatry, New York University Medical Center. Areas of Research: Psychopharmacological Treatment of Children with Autism and Children with Conduct Disorder. Learning And Selective Attention In Children with Autism.

- 1 -

1975-77 National Institute of Mental Health Post-Doctoral Fellow in Experimental Psychopathology. Research directed by Dr. M. Alpert, NYU Medical Center. 1975 Research Consultant to Dr. A.J. Berman, Dept. of Neurology, Veterans Administration Hospital, Bronx, NY. 1971-73 Doctoral Candidate. Research directed by Dr. M.R. D'Amato, Psychology Dept., Rutgers University. 1969-71 Master's Candidate. Research Directed by Dr. J. Mendelson, Brain Research Laboratory, Rutgers University. Doctoral Dissertation: Schedule-Induced Behaviors: Interactions among Consummatory Reinforcers and Intracranial Stimulation.

Grants Received 2003-06 Principal Investigator, Familial Mood Disorders, Genetics, and Outcome in Children with PDD. March of Dimes 2001-06 Co-Investigator, Unraveling the Mystery of Autism Spectrum Disorders (ASDs): From Genotyping and Phenotyping to Prospective Identification and Treatment, Jeanette Holden, PI., Canadian Institutes for Health Research 2000-02 Principal Investigator, Epidemiology of Autism on Staten Island, National Alliance

for Autism Research 1999-02 Principal Investigator, Effects of Parental Depression on Toddlers with PDD,

March of Dimes 1995-97 Principal Investigator, Early Intervention Behavioral Research Program for Children with Autism, Research Foundation for Mental Hygiene. 1993-95 Principal Investigator, Artificial Neural Network Classification of Autism, Research Foundation for Mental Hygiene. 1984-89 Principal Investigator, Infantile Autism and the Fragile X Syndrome, National Institute of Mental Health. 1985-87 Principal Investigator, Revision of Resource Directory of Agencies Serving Autistic Individuals, Biomedical Research Support Grant 1985-86 Principal Investigator, Reliability and Validity of the Autistic Descriptors Checklist, Biomedical Research Support Grant 1984-85 Co-Principal Investigator, Effects of Folic Acid on the Treatment of Fragile X Autistic Individuals, Stallone Foundation.

- 2 -

1984-85 Co-Principal Investigator, Effects of Fenfluramine in Autism: A Multicenter Study, Biomedical Research Support Grant. 1983-84 Co-Principal Investigator, Infantile Autism and the Fragile X Syndrome, National Institute of Mental Health. 1983-84 Co-Principal Investigator, Development of a Valid Assessment Scale for Autism, ADAMHA. Academic Positions 1991- Adjunct Professor. Dept. of Psychology, The Graduate School and University Center of The City University of New York 1988-92 Visiting Part-Time Lecturer. Dept. of Psychology, Rutgers-The State University, New Brunswick, NJ. 1980-82 Research Assistant Professor. Dept. of Psychiatry, NYU Medical Center. 1975-80 Instructor and Teaching Assistant. Dept. of Psychiatry, NYU Medical Center. 1974-77 Instructor and Adjunct Instructor. Dept. of Psychology, Kean College, Union, NJ. 1974 Adjunct Assistant Professor. Dept. of Psychology, Lehman College, CUNY, Bronx, NY. 1974 Adjunct Assistant Professor. Dept. of Psychology, Seton Hall University, South Orange, NJ. 1971-75 Adjunct Instructor and Teaching Assistant. Dept. of Psychology, Rutgers- The State University. Courses Taught: Atypical Development of Childhood and Adolescence Behavior Modification Behavioral Disorders of Childhood Behavioral Pharmacology Child Rearing Developmental Psychology Drugs and Human Behavior Experimental Psychology Introductory Psychology Learning Perception Physiological Psychology Research Methodology and Behavioral Measurement

- 3 -

Previous Clinical Positions: 1981-82 Director of Community Readiness Unit. Joint project between New York University Medical Center and Staten Island Developmental Center. 1980-87 Consultant in Behavior Modification. Association for the Advancement of the Blind and Retarded. 1978 Behavior Therapist. Group for Psychological Counseling, New York, NY. 1978 Consultant in Behavior Modification. Staten Island Developmental Center. 1977-78 Behavior Therapist. Center for Counseling and Behavior Therapy. New York, NY. 1975-77 Clinical training in Behavior Therapy. Outpatient Psychiatric Clinic at Millhauser Laboratories, NYU Medical Center, Lowell T. Anderson, Ph.D., Supervisor. Licenses NYS License for Practice in Psychology: # 005918 Honors: American Association on Mental Retardation - Membership Recognition Award, 1992 Autism Foundation of New York, Autism Advocacy Outreach Group, Recognition Award for years of

commitment and dedication, March, 2000, First Annual Dinner Dance. Fellow, American Psychological Society, August, 1995 Invited to be Panel Discussant for Dr. Allan Reiss’ presentation at the Research Scientist

Development Awardee Conference, National Institute of Mental Health, Chevy Chase, MD, June, 1990.

National Institute of Mental Health Post-Doctoral Fellowship Award, 1975-1977 National Society for Children and Adults with Autism - Award for Service to Persons with Autism,

1987 United States Military Academy at West Point - Award for presentation at “Partnership in Caring:

Vision for the 21st Century” meeting, 1995 Who's Who in the East Who's Who in Frontiers of Science and Technology.

- 4 -

Federal Government Review Committees: National Institute on Child Health and Human Development, Special Review Committee, July, 1989 Reviewers Reserve, National Institute of Mental Health, Child Psychopathology and Treatment

Review Committee, July, ‘93 - June, ‘94 Member, Child Psychopathology and Treatment Review Committee, National Institute of Mental

Health, July, 1994 - June, 1996. Asked to continue as committee member, July, 1996-June, 1999.

Member, Child Psychopathology and Treatment Review Committee, National Institute of Mental Health, July, 1996-June, 1997.

Member, CSR Special Emphasis Panel on Autism Centers of Excellence: The STAART Program, BBBP-6, National Institutes of Health. March, 2002. Member, Special Emphasis Panel on Fragile X Research Centers, ZHD1 MRG-C. National Institute of Child Health and Human Development. November, 2002. Member, PRMRP Autism Panel, American Institute of Biological Sciences, U.S. Army Medical Research and Materiel Command, May 2 – 3, 2005. Guest Reviewer: American Journal of Human Genetics American Journal of Medical Genetics American Journal on Mental Retardation Biological Psychiatry Clinical Genetics Developmental Brain Dysfunction Johns Hopkins University Press Journal of Autism and Developmental Disorders March of Dimes Foundation Nature Medicine Proceedings of the National Academy of Sciences Psychiatric Research Psychoneuroendocrinology Past and Present Professional Memberships: American Association for the Advancement of Science American Psychological Association American Association on Mental Retardation American Psychological Society (Charter Member and Fellow) Association for the Advancement of Behavior Therapy Autism Society of America International Neural Network Society International Society for Autism Research Society for Neuroscience Society for Research in Child Development

- 5 -

Institutional Appointments Library Committee - IBR/DD 1992- Promotions Committee - IBR/DD 1993-1996 Institutional Review Board - IBR/DD 1997-2002 Internal Research Review Committee – IBR/DD 2001- Chairman, Promotions Committee – IBR/DD 2005-06 Professional Committees: Conference Advisory Committee for Third International Fragile X Conference, Snowmass/Aspen,

CO, June 16-20, 1992. Organizing Committee for The First Northeast Fragile X Conference for Parents and Professionals,

Tarrytown, NY October 25-26, 1992. Conference Advisory Committee for Fourth International Fragile X Conference, Albuquerque, NM

June 8-12, 1994. Organizing Committee for The Second Northeast Fragile X Conference for Parents and

Professionals, Tarrytown, NY November 13-14, 1994. Chair, Organizing Committee for IBR’s first conference on autism: Autism: Biological, Behavioral

and Cognitive Issues in Intervention. Conference participants: Mary Coleman, John Tsiouris, Raymond Romanczyk, Mary Jane Weiss, Alan Leslie, Vicki Sudhalter and me. June 7, 1996.

Consensus Panel for the Development of Clinical Practice Guidelines on Autism/Pervasive

Developmental Disorders. New York State Early Intervention Program. New York State Department of Health. 1997-99.

Professional Advisory Boards Past Member of Human Rights Committee - Eden II School for Autistic Children, Inc., Staten Island,

NY. Professional Advisory Board, Foundation for Educating Children with Autism, Inc. Scientific Advisory Board, Associazione Italiana Per la Ricerca sulle Psicosi e l’Autismo (ARPA),

Rome, Italy. Professional Advisory Board, Institute for Child Development, Binghamton University (SUNY-

Binghamton). Board of Advisors, Foundation for Children with Developmental Disabilities, Rockland County, NY Past Member of Professional Advisory Board, Association in Manhattan for Autistic Children

(AMAC). Past Member of Professional Advisory Board, Autism Advocacy Outreach Group (AAOG), Staten

Island, NY Past Member, Board of Directors, Association for Science in Autism Treatment Past Chair, Advisory Board, Association for Science in Autism Treatment

- 6 -

Publications

-1973- 1. Cohen, I.L. (1973). A note on Herrnstein's equation. Journal of the Experimental Analysis of

Behavior, 19, 527-528.

-1974-

2. Cohen, I.L. & Mendelson, J. (1974). Schedule-induced drinking with food, but not ICS, reinforcement. Behavioral Biology, 12, 21-29.

-1975-

3. Cohen, I.L. (1975). The reinforcement value of schedule-induced drinking. Journal of the

Experimental Analysis of Behavior, 23, 37-44.

-1977- 4. Campbell, M., Geller, B. & Cohen, I.L. (1977). Current status of drug research and treatment

with autistic children. Journal of Pediatric Psychology, 4, 153-161.

-1978- 5. Campbell, M., Small, A.M., Hollander, C.S., Korein, J., Cohen, I.L., Mieke, K. & Ferris, S. (1978).

A controlled crossover study of triiodothyronine in autistic children. Journal of Autism and Childhood Schizophrenia, 8, 371-381.

6. Campbell, M. & Cohen, I.L. (1978). Drug therapy of child psychoses. Resident and Staff

Physician, 24, 115-118. 7. Campbell, M. & Cohen, I.L. (1978). Treatment of infantile autism. Comprehensive Therapy, 4,

33-37. 8. Campbell, M., Anderson, L.T., Meier, M., Cohen, I.L., Small, A.M., Samit, C. & Sachar, E.J.

(1978). A comparison of haloperidol and behavior therapy and their interaction in autistic children. Journal of the American Academy of Child Psychiatry, 7, 640-655.

9. Campbell, M. & Cohen, I.L. (1978). Pharmacotherapy of behavioral disorders in children.

Weekly Psychiatric Update Series, 2, 2-7. 10. Cohen, I.L., Anderson, L.T. & Campbell, M. (1978). Measurement of drug effects in autistic

children. Psychopharmacology Bulletin, 14, 68-70.

- 7 -

-1979-

11. Campbell, M., Anderson, L.T., Meier, M., Cohen, I.L., Small, A.M. & Sachar, E.J. (1979). A

comparison of haloperidol, behavior therapy and their interaction in autistic children. Psychopharmacology Bulletin, 15, 84-86.

12. Campbell, M., Anderson, L.T., Meier, M., Cohen, I.L., Small, A.M., Samit, C. & Sachar, E.J.

(1979). A Comparison of haloperidol and behavior therapy and their interaction in autistic children. Digest of Neurology and Psychiatry, Series XLVII, 134 (abstract).

13. Campbell, M., Anderson, L.T., Meier, M., Cohen, I.L., Small, A.M., Samit, C. & Sachar, E.J.

(1979). Comparison of haloperidol and behavior therapy and their interaction in autistic children. Psychiatric Digest. (abstract).

14. Campbell, M., Anderson, L.T., Meier, M., Cohen, I.L., Small, A.M., Samit, C. & Sachar, E.J.

(1979). Haloperidol and behavior therapy effective in autism. International Medical News. (abstract)

-1980-

15. Campbell, M., Cohen, I.L., & Anderson, L.T. (1980). New approaches in the treatment of

autistic children. Abstracts of the 12th CINP Congress, Goteborg, Sweden. Pergamon Press, Oxford, p. 99

16. Campbell, M., Anderson, L.T., Meier, M., Cohen, I.L., Small, A.M., Samit, C. & Sachar, E.J.

(1980). Comparison of haloperidol and behavior therapy and their interaction in autistic children. Medilix Digest Psychiatry, 84. (abstract).

17. Campbell, M., Petti, T.A., Green, W.H., Cohen, I.L., Genieser, N.B. & David, R. (1980). Some

physical parameters of young autistic children. Journal of the American Academy of Child Psychiatry, 19, 193-212.

18. Cohen, I.L., Campbell, M., Posner, D., Small, A., Triebel, D. & Anderson, L. (1980). Behavioral

effects of haloperidol in young autistic children: An objective analysis using a within-subjects reversal design. Journal of the American Academy of Child Psychiatry, 19, 665-677.

19. Cohen, I.L., Campbell, M., Posner, D., Triebel, D., Small., A.M., & Anderson, L.T. (1980). A

study of haloperidol in young autistic children: a within-subjects design using objective rating scales. Psychopharmacology Bulletin, 16, 63-65.

-1981-

20. Campbell, M., Anderson, L.T., Cohen, I.L., Perry, R., Small, A.M., Green, W.H. & Caplan, R.

(1981). Effects of haloperidol on behavioral symptoms and learning in autistic children. Proceedings of the IIIrd World Congress on Biological Psychiatry. 1 Abstracts, 47.

- 8 -

21. Campbell, M., Anderson, L.T., Cohen, I.L., Perry, R., Small, A.M., Green, W.H. & Caplan, R. (1981). Effects of haloperidol on behavioral symptoms and learning in autistic children. In C. Perris, G. Struwe & B. Jansson (Eds.), Biological Psychiatry 1981. Proceedings of the IIIrd World Congress on Biological Psychiatry. Amsterdam, Elsevier: North-Holland Biomedical Press, pp. 1023-1026.

22. Campbell, M. & Cohen, I.L. (1981). Psychotropic drugs in child psychiatry. In H.M. van Praag,

M.H. Lader, O.J. Rafaelsen & E.J. Sachar (Eds.), Handbook of Biological Psychiatry. NY: Marcel Dekker.

23. Campbell, M., Anderson, L.T., Cohen, I.L., Perry, R., Small, A.M., Green, W.H. & Caplan, R.

(1981). Effects of haloperidol on behavioral symptoms and learning in autistic children. Biological Psychiatry, 1023-1026.

24. Campbell, M., Cohen, I.L. & Anderson, L.T. (1981). Pharmacotherapy for autistic children: A

summary of research. Canadian Journal of Psychiatry, 26, 265-273. 25. Platt, J.E., Campbell, M., Green, W.H., Perry, R. & Cohen, I.L. (1981). Effects of lithium

carbonate and haloperidol on cognition in aggressive hospitalized school-age children. Journal of Clinical Psychopharmacology, 1, 8-13.

26. Platt, J.E., Campbell, M., & Cohen, I.L. (1981). Effects of lithium carbonate and haloperidol on

cognition in aggressive hospitalized school-age children. Psychopharmacology Bulletin, 17(1): 123-125.

27. Campbell, M, Cohen, I.L. & Anderson, L.T. (1981). Pharmacotherapy for autistic children: A

summary of research. International Synopses, Psychiatry. (abstract).

-1982-

28. Campbell, M., Cohen, I.L. & Anderson, L.T. (1982). Pharmacotherapy for autistic children. Psychiatry Digest, 14. (abstract).

29. Campbell, M., Anderson, L.T., Cohen, I.L., Perry, R., Small, A.M., Green, W.H., Anderson, L. &

McCandless, W.H. (1982). Haloperidol in autistic children: Effects on learning, behavior and abnormal involuntary movements. Psychopharmacology Bulletin, 18, 110-112.

30. Campbell, M., Cohen, I.L. & Small, A.M. (1982). Drugs in aggressive behavior. Journal of the

American Academy of Child Psychiatry, 21, 107-117. 31. Platt, J.E., Cohen, I.L. & Campbell, M. (1982). Assessment of infants. In Burdock, E.I.,

Sudilovsky, A. & Gershon, S. (Eds.), The Behavior of Psychiatric Patients: Quantitative Techniques for Evaluation. pp. 213-250. NY: Marcel Dekker.

32. Petti, T.A., Fish, B., Shapiro, T., Cohen, I.L. & Campbell, M. (1982). Effects of chlordiazepoxide

in disturbed children: A pilot study. Journal of Clinical Psychopharmacology, 2, 270-273.

- 9 -

-1983-

33. Campbell, M., Cohen, I.L. & Perry, R. (1983). Psychopharmacological treatment. In T.H. Ollendick & M. Hersen (Eds.), Handbook of Child Psychopathology. pp. 461-484. NY: Plenum.

-1984

34. Brown, W.T., Jenkins, E.C., Friedman, E., Brooks, J., Cohen, I.L., Duncan, C., Hill, A.L., Malik, M.N., Morris, V., Wolf, E., Wisniewski, K. & French, J.H. (1984). Folic acid in the fragile X syndrome. American Journal of Medical Genetics, 17, 289-297.

35. Cohen, I.L. (1984). Establishment of independent responding to a fire alarm in a blind,

profoundly retarded adult. Journal of Behavior Therapy & Experimental Psychiatry, 15, 365-367.

36. Cohen, I.L. (1984). There is no "right answer". American Psychologist, 39(5), 55-56. 37. Jenkins, E.C., Brown, W.T., Krawczun, M.S., Duncan, C.J., Brooks, J., Gross, A., Lele, K.P.,

Masia, A., Nolin, S.L., Sanz, M.M. & Cohen, I.L. (1984). Fra(X) (p22) not associated with infantile autism. Lancet, II, 1397.

-1985-

38. Brown, W.T., Gross, A., Chan, C., Jenkins, E.C. & Cohen, I.L. (1985). Genetic heterogeneity in

fragile X syndrome: Evidence from RFLP linkage analysis and clinical expression. American Journal of Human Genetics, 37(4), A189.

39. Cohen, I.L., Fisch, G.S., Wolf-Schein, E.G., Friedman, E., Jenkins, E.C. & Brown, W.T. (1985).

Fragile X and autism: Preliminary analysis of non-verbal behavioral characteristics. American Journal of Human Genetics, 37(4), A50.

40. Fisch, G.S., Cohen, I.L., Wolf, E.G. & Friedman, E. (1985). The Autistic Descriptors Checklist

(ADC): A preliminary report. Journal of Autism and Developmental Disorders, 15, 233. 41. Fisch, G.S., Brown, W.T., Cohen, I.L. & Jenkins, E.C. (1985). An increased risk of fragile X

among Jewish people?. American Journal of Human Genetics, 37(4), A196. 42. Wolf, E.G., Fisch, G.S. & Cohen, I.L. (1985). Nonverbal systems of autistic individuals: An

ecological study. Journal of Dance Therapy, 8, 67-80.

-1986-

43. Brown, W.T., Jenkins, E.C., Krawczun, M.S., Wisniewski, K., Rudelli, R., Cohen, I.L., Fisch, G.S., Wolf-Schein, E.G., Miezejeski, C. & Dobkin, C. (1986). The fragile X syndrome. Mental Retardation: Research, Education and Technology Transfer, 477, 129-150.

- 10 -

44. Brown, W.T., Jenkins, E.C., Gross, A.C., Chan, C.B., Krawczun, M.S., Duncan, C.J., Sklower,

S.L., Wisniewski, K., Fisch, G.S., Cohen, I.L., Wolf-Schein, E.G. & Miezejeski, C.M. (1986). Evidence for genetic heterogeneity in the fragile X syndrome. American Journal of Human Genetics, 39(3), A231.

45. Brown, W.T., Jenkins, E.C., Cohen, I.L., Fisch, G.S., Wolf-Schein, E.G., Gross, A.,

Waterhouse, L., Fein, D., Mason-Brothers, A., Ritvo, E., Ruttenberg, B.A. & Bentley, S.C. (1986). Fragile X and autism: A multicenter survey. American Journal of Medical Genetics, 23, 341-352.

46. Brown, W.T., Jenkins, E., Krawczun, M.S., Wisniewski, K., Rudelli, R., Cohen, I.L., Fisch, G.,

Wolf-Schein, E., Miezejeski, C.M. & Dobkin, C. (1986). The fragile X syndrome. Annals of the New York Academy of Science, 477, 129-150.

47. Fisch, G.S., Cohen, I.L., Wolf, E.G., Brown, W.T., Jenkins, E. & Gross, A. (1986). Autism and

the fragile X syndrome. American Journal of Psychiatry, 143, 71-73.

-1987-

48. Brown, W.T., Jenkins, E.C., Gross, A.C., Chan, B.C., Wisniewski, K., Cohen, I.L. & Miezejeski, C.M. (1987). Genetics and expressions of the fragile X syndrome. Upsala Journal of Medical Science, 44, 137-154.

49. Wolf-Schein, E.G., Sudhalter, V., Cohen, I.L., Fisch, G.S., Hanson, D., Pfadt, A.G., Hagerman,

R., Jenkins, E.C. & Brown, W.T. (1987). Speech-language and the fragile X syndrome: Initial Findings. ASHA, July, 35-38.

-1988-

50. Campbell, M., Cohen, I.L., Perry, R. & Small, A.M. (1988). Psychopharmacological treatment.

In T.H. Ollendick & M. Hersen (Eds.), Handbook of Child Psychopathology. NY: Plenum.

51. Cohen, I.L., Fisch, G.S., Wolf-Schein, E.G., Sudhalter, V., Hanson, D., Hagerman, R., Jenkins,

E.C. & Brown, W.T. (1988). Social gaze, social avoidance and repetitive behavior in fragile X males: A controlled study. American Journal of Mental Retardation, 92, 436-446.

52. Fisch, G.S., Cohen, I.L., Jenkins, E.C. & Brown, W.T. (1988). Screening developmentally

disabled male populations for fragile X: The effect of sample size. American Journal of Medical Genetics, 30, 655-663.

53. Fisch, G.S., Cohen, I.L., Gross, A.C., Jenkins, V., Jenkins, E.C. & Brown, W.T. (1988). Folic

acid treatment of fragile X males: A further study. American Journal of Medical Genetics, 30, 393-399.

- 11 -

54. Wolf-Schein, E.G., Jenkins, E.C., Sklower, S., Cohen, I.L., Wisniewski, K.E. & Brown, W.T. (1988). On the association of fragile X with autism. Journal of Autism and Developmental Disorders, 18(3), 457-458.

-1989-

55. Cohen, I.L., Vietze, P., Sudhalter, V., Jenkins, E.C. & Brown, W.T. (1989). Parent-child dyadic

gaze patterns in fragile X males and in non-fragile X males with autistic disorder. Journal of Child Psychology and Psychiatry, 30(6), 845-856.

56. Cohen, I.L., Brown, W.T., Jenkins, E.C., Krawczun, M.S., French, J.H., Raguthu, S., Wolf-

Schein, E.G., Sudhalter, V., Fisch, G. & Wisniewski, K. (1989). Fragile X syndrome in females with autism. American Journal of Medical Genetics, 34, 302-303.

-1990-

57. Sudhalter, V., Cohen, I.L., Silverman, W. & Wolf-Schein, E.G. (1990). Conversational analyses

of males with fragile X, Down syndrome and autism: A comparison of the emergence of deviant language. American Journal of Mental Retardation, 94, 431-441.

-1991-

58. Cohen, I.L., Vietze, P., Sudhalter, V., Jenkins, E.C. & Brown, W.T. (1991). Effects of age and

communication level on eye contact in fragile X males and non-fragile X autistic males. American Journal of Medical Genetics, 38, 498-502.

59. Sklower Brooks, S., Cohen, I., Ferrando, C., Jenkins, E.C., Brown, W.T. & Dobkin, C. (1991).

Cytogenetic negative, linkage positive "fragile X" syndrome. American Journal of Medical Genetics, 38, 370-373.

60. Sudhalter, V., Scarborough, H. & Cohen, I.L. (1991). The syntactic delay and pragmatic

deviance of the language of Fragile X males. American Journal of Medical Genetics, 38, 493-497.

61. Cohen, I.L., Sudhalter, V., Pfadt, A., Jenkins, E.C., Brown, W.T. & Vietze, P.M. (1991). Why

are autism and the fragile X syndrome associated? Conceptual and methodological issues. American Journal of Human Genetics, 48(2), 195-202.

62. Cohen, I.L., Tsiouris, J.A. & Pfadt, A. (1991). Effects of long-acting propranolol on agonistic and

stereotyped behaviors in a male with pervasive developmental disorder and fragile X syndrome: A double-blind, placebo controlled study. Journal of Clinical Psychopharmacology, 11(6), 898-899.

- 12 -

-1992-

63. Hinton, V.J., Dobkin, C.C., Halperin, J.M., Jenkins, E.C., Brown, W.T., Ding, X.H., Cohen, I.L.,

Rousseau, F. & Miezejeski, C.M. (1992). Mode of inheritance influences behavioral expression and molecular control of cognitive deficits in female carriers of the fragile X syndrome. American Journal of Medical Genetics, 43, 87-95.

64. Reiss, A.L., Cianchetti, C., Cohen, I.L., DeVries, B., Hagerman, R., Hinton, V., Froster, U.,

Lachiewicz, A., Mazzocco, M., Sobesky, W., & Sudhalter, V. (1992). A brief screening questionnaire for determining affected state in fragile X syndrome: A consensus recommendation. American Journal of Medical Genetics, 43, 61-64.

65. Pfadt, A., Cohen, I.L., Sudhalter, V., Romanczyk, R. & Wheeler, D.J. (1992). Applying statistical

process control to clinical data: An illustration. Journal of Applied Behavior Analysis, 25, 551-560.

66. Cohen, I.L. (1992). The behavioral phenotype of Fragile X Syndrome and its association with

autism. Proceedings of the Third International Fragile X Conference. Denver: Spectra Publishing.

-1993-

67. Cohen, I.L., Sudhalter, V., Landon-Jimenez, D. & Keogh, M. (1993). A neural network approach

to the classification of autism. Journal of Autism and Developmental Disorders, 23, 443-466.

68. Cohen, I.L. (1993). Artificial neural network classification of behavioral subtypes of autism and

fragile X syndrome. Developmental Brain Dysfunction, 6, 353-354 (abstract).

-1994-

69. Cohen, I.L. (1994). An artificial neural network analogue of learning in autism. Biological Psychiatry, 36, 5-20.

70. Cohen, I.L., Sudhalter, V., Landon-Jimenez, D. & Keogh, M. (May/June 1994). Diagnosing

autism: A neural net-based tool. PCAI, 22-25.

-1995-

71. Perry, R., Cohen, I.L., & DeCarlo, R. (1995). Deterioration, autism and recovery in two siblings with follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 232-237.

72. Cohen, I.L. (1995). Behavioral profiles of autistic and non-autistic fragile X males.

Developmental Brain Dysfunction, 8, 252-269.

- 13 -

-1996-

73. Cohen, I.L. (1996). A theoretical analysis of the role of hyperarousal in the behavior and

learning of fragile X males. Mental Retardation and Developmental Disabilities Research Reviews, 1, 4, 286-291 (invited article).

74. Cohen, I.L., Nolin, S.L., Sudhalter,V., Ding, X-H, Dobkin, C.S. and Brown, W.T. (1996).

Mosaicism for the FMR1 gene influences adaptive skills development in fragile X affected males. American Journal of Medical Genetics, 64, 365-369.

75. Dobkin, C.S., Nolin, S.L., Cohen, I., Sudhalter, V., Bialer, M., Ding, X-H, Jenkins, E.C.,

Zhong, N., and Brown, W.T. (1996). Tissue differences in fragile X mosaics: Mosaicism in blood cells may differ greatly from skin. American Journal of Medical Genetics, 64, 296-301.

76. Dykens, E., Ort, S., Cohen, I., Finucane, B., Spiridigliozzi, G., Lachiewicz, A., Reiss, A.,

Freund, L., Hagerman, R., and O’Connor, R. (1996). Trajectories and profiles of adaptive behavior in males with fragile X syndrome. Journal of Autism and Developmental Disorders, 26, 287-301.

-1997-

77. Linday, L.A., Cohen, I.L., Tsiouris, J.A., and DeCresce, R. (1997). Famotidine treatment of

three children with autistic spectrum disorders (abstract). AACAP/CACP Scientific Proceedings, XIII:133.

78. Linday, L.A., Cohen, I.L., Tsiouris, J.A., and DeCresce, R. (1997). Famotidine treatment of

three children with autistic spectrum disorders (abstract). In Scientific Proceedings, 44th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Toronto, Canada, October 14-19, NR-125.

-1998-

79. Cohen, I.L. (1998). Neural network analysis of learning in autism. In D.J. Stein and J. Ludik

(Eds.) Neural Networks and Psychopathology. New York: Cambridge University Press, 274-315.

80. Cohen, I.L. (1998). The genetics of autism. The Genetic Resource, 11, 10-14.

-1999- 81. Zhong, N., Ye, L., Ju, W., Tsiouris, J., Cohen, I., and Brown, W.T. (1999). 5-HTTLPR

variants not associated with autistic spectrum disorders. Neurogenetics, 2, 129-131.

- 14 -

82. Phillippe, A., Martinez, M., Guilloud-Bataille, M., Gillberg, C., Rastam, M., Sponheim, E.,

Coleman, M., Zappella, M., Aschauer, H., van Malldergerme, L., Penet, C., Feingold, J., Brice, A., Leboyer, M., and the Paris Autism International Sibpair Study (1999). Genome-wide scan for autism susceptibility genes. Human Molecular Genetics, 8(5), 805-812.

-2000-

83. Tsiouris, J.A., Mehta, P., Patti, P., Madrid, R.E., Raguthu, S., Barshatzky, M.R., Cohen, I.L.,

and Sersen, E (2000). Alpha2 macroglobulin elevation without an acute phase response in depressed adults with Down syndrome: Implications. Journal of Intellectual Disability Research, 44(6), 644-653.

-2001-

84. Linday, L.A., Tsiouris, J.A., Cohen, I.L., Shindledecker, R., and DeCresce, R. (2001).

Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design. Journal of Neural Transmission, 108, 593-611.

-2002-

85. Philippe, A., Guilloud-Bataille, M., Martinez, M., Gillberg, C., Råstam, M., Sponheim, E.,

Coleman, M., Zappella, M., Aschauer, H., Penet, C., Feingold, J. , Brice, A., Leboyer, M. and the Paris Autism Research International Sibpair Study (2002). Analysis of ten candidate genes in autism by association and linkage. American Journal of Medical Genetics, 114(2),125-128.

86. Betancur, C., Corbex, M., Spielewoy, C., Phillipe, A., Laplanche, J-L., Launay, J-M.,

Gillberg, C., Mouren-Simeoni, M-C., Hamon, M., Giros, B., Nosten-Bertrand, M., Leboyer, M., and the Paris Autism Research International Sibpair Study (2002). Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Molecular Psychiatry, 7, 67-71.

87. Jamain, S., Betancur, C., Quach, H., Philippe, A., Fellous, M., Giros, B., Gillberg, C.,

Leboyer, M., Bourgeron, T., and the Paris Autism Research International Sibpair Study (2002). Linkage and association of the glutamate receptor 6 gene with autism. Molecular Psychiatry, 7, 302-310.

88. Krebs, M.O., Betancur, C., Leroy, S., Bourdel, M.C..., Gillberg, C., Leboyer, M., and the

Paris Autism Research International Sibpair Study (2002). Absence of association between a polymorphic GGC repeat in the 5’ untranslated region of the reelin gene and autism. Molecular Psychiatry, 7, 801-804.

-2003-

89. Cohen, I.L., Schmidt-Lackner, S., Romanczyk, R., and Sudhalter, V. (2003). The PDD

Behavior Inventory: A rating scale for assessing response to intervention in children with PDD. Journal of Autism and Developmental Disorders, 33(1), 31-45.

- 15 -

90. Cohen, I.L. (2003). Criterion-related validity of the PDD Behavior Inventory. Journal of

Autism and Developmental Disorders, 33(1), 47-53. 91. Jamain, S., Quach, H., Betancur, C., Råstum, M., Colineaux, C., Gillberg, I.C., Soderstrom,

S., Giros, B., Leboyer, M., Gillberg, C. and the Paris Autism Research International Sibpair Study (2003). Mutations of the X-linked genes encoding NLGN3 and NLGN4 are associated with autism. Nature Genetics, advanced online publication.

92. Cohen, I.L., Liu, X., Schutz, C., White, B.N., Jenkins, E.C., Brown, W.T., and Holden, J.J.A.

(2003). Association of autism severity with a monoamine oxidase A functional polymorphism. Clinical Genetics, 64, 190-197.

93. Tsiouris, J.A., Cohen, I.L., Patti, P.J., and Korosh, W.M. (2003). Treatment of previously

undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior. Journal of Clinical Psychiatry, 62 (9), 1081-1090.

-2004-

94. Chauhan, V., Chauhan, A., Cohen, I.L., Brown, W.T., Sheikh, A. (2004). Alteration in amino-

glycerophospholipids levels in the plasma of children with autism: A potential biochemical diagnostic marker. Life Sciences, 74, 1635-1643.

95. Chauhan, A., Chauhan, V., Brown, W.T., and Cohen, I.L. (2004). Oxidative stress in autism:

Increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin – the antioxidant proteins. Life Sciences, 75, 2539-2549.

-2005-

96. Cohen, I.L. and Sudhalter, V. (2005). The PDD Behavior Inventory. Lutz, FL:

Psychological Assessment Resources, Inc.

-2006- 97. Cohen, I.L. (2006). A neural network model of autism: Implications for theory and treatment.

In D. Mareschal, S. Sirois, G. Westerman, and M.H. Johnson (eds). Neuroconstructivism. Vol. 2: Perspectives and Prospects. Oxford: Oxford University Press, 227-260.

98. Cohen, I.L. and Tsiouris, J.A. (2006). Maternal recurrent mood disorders and high-

functioning autism. Journal of Autism and Developmental Disorders, 1-12.

- 16 -

Posters and Professional Presentations

-1977- 1. Cohen, I.L., Anderson, L.T. & Campbell, M. (1977). Measurement of drug effects in autistic

children. Paper presented at the American College of Neuropharmacology Meeting, Puerto Rico, December.

2. Campbell, M., Anderson, L.T., Meier, M., Cohen, I.L. & Small, A.M. (1977). New research

approaches in infantile autism. Paper presented at the VI World Congress of Psychiatry, Honolulu, August September.

-1978-

3. Cohen, I.L. & Anderson, L.T. (1978) Behavior therapy in the community. Lecture presented at

NYU Medical Center. January. 4. Campbell, M., Green, W.H., Petti, T.A. & Cohen, I.L. (1978). Effects of haloperidol, behavior

therapy and their interaction in autistic children. Paper presented at the NCDEU Meeting, Key Biscayne, October.

5. Campbell, M., Petti, T.A., Green, W.H. & Cohen, I.L. (1978). Some physical parameters of

young autistic children. Paper presented at the Twenty Fifth Annual Meeting of the American Academy of Child Psychiatry, October.

-1979-

6. Cohen, I.L., Campbell, M., Posner, D., Triebel, D., Small, A.M. & Anderson, L.T. (1979). A study

of haloperidol in young autistic children: A within-subjects design using objective rating scales. Paper presented at the NCDEU meeting, Key Biscayne, May.

7. Campbell, M., Cohen, I.L. & Anderson, L.T. (1979). A comparison of haloperidol and behavior

therapy and the combination of both in autistic children. Paper presented at the Annual Meeting of the American Psychological Association, New York, September.

8. Campbell, M. & Cohen, I.L. (1979). Pharmacotherapy for autistic children. 1979 Symposium:

Pharmacotherapy with Emotionally Disturbed Children. Thistletown Regional Centre and University of Toronto, Toronto, September.

9. Campbell, M. & Cohen, I.L. (1979). Workshop: Behavior modification, milieu therapy and drugs

in the treatment of infantile autism. 1979 Symposium: Pharmacotherapy with Emotionally Disturbed Children. Thistletown Regional Centre and University of Toronto, Toronto, September.

10. Cohen, I.L., Campbell, M., Posner, D., Small, A.M., Triebel, D. & Anderson, L.T. (1979). A study

of haloperidol in young autistic children: A within-subjects design using objective rating scales. Paper presented at the 26th Annual Meeting of the American Academy of Child Psychiatry, Atlanta, October.

- 17 -

-1980- 11. Cohen, I.L. (1980). Psychopharmacology in the treatment of autistic children. Lecture

presented at Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel, July. 12. Campbell, M., Platt, J.E. & Cohen, I.L. (1980). Effects of lithium carbonate and haloperidol on

cognition in aggressive, hospitalized, schoolage children. Paper presented at the NCDEU Annual Meeting, Key Biscayne, May.

13. Cohen, I.L., Campbell, M., McCandless, W. & Posner, D. (1980). A timed objective rating scale

for autistic children: Comparison of preschool age patients and normal controls. Paper presented at the 27th Annual Meeting of the American Academy of Child Psychiatry, Chicago, October.

14. Campbell., M., Cohen, I.L. & Anderson, L.T. (1980). New approaches in the treatment of

autistic children. Paper presented at the 12th CINP Congress, Goteborg, Sweden, June.

-1981- 15. Campbell, M., Anderson, L.T., Cohen, I.L., Perry, R., Small, A.M., Green, W.H., Anderson, L. &

McCandless, W. (1981). Haloperidol in autistic children: Effects on learning, behavior and abnormal involuntary movements. Paper presented at the NCDEU Annual Meeting, Key Biscayne, May.

16. Campbell, M., Anderson, L.T., Cohen, I.L., Perry, R., Small, A.M., Green, W.H., & Caplan, R.

(1981). Effects of haloperidol on behavioral symptoms and learning in autistic children Paper presented at the IIIrd World Congress of Biological Psychiatry, Stockholm, Sweden, June 28-July 3.

17. Campbell, M., Petti, T., Fish, B., Shapiro, T. & Cohen, I.L. (1981). Chlordiazepoxide treatment

of disturbed children. Paper presented at the Twenty-Eighth Annual Meeting of the American Academy of Child Psychiatry, Dallas, October.

18. Petti, T., Fish, B., Shapiro, T., Cohen, I.L. & Campbell, M. (1981). Chlordiazepoxide treatment

of disturbed children. Paper presented at the 28th Annual Meeting of the American Academy of Child Psychiatry, Dallas, October.

-1982-

19. Friedman, E., Wolf, E.G. & Cohen, I.L. (1982). The genetic aspects of autism. Paper

presented at the Fourth International Conference in Neuroscience and Education. Columbia University, New York, March.

20. Friedman, E., Brown, W.T., Jenkins, E., Cohen, I.L. & Wolf, E.G. (1982). The fragile X

syndrome and autism. Paper presented at the National Conference for Parents and Professionals, National Society for Children and Adults with Autism, Omaha, NE, July.

- 18 -

21. Friedman, E., Wolf, E. & Cohen, I.L. (1982). Early infantile autism: The diagnostic puzzle.

Paper presented at the 6th International Congress of the International Association for the Scientific Study of Mental Deficiency, Toronto, August.

-1983-

22. Cohen, I.L. (1983). The Autistic Descriptors Checklist. Paper presented at workshop entitled

Services for the Autistic Adolescent: Assessments, Parenting, Innovative Programs, Teachers College, Columbia University, New York, April.

-1984-

23. Cohen, I.L. (1984). The Autistic Descriptors Checklist (ADC): Research findings. Paper

presented at the 108th Annual Meeting of the American Association on Mental Deficiency, Minneapolis, May.

-1985-

24. Cohen, I.L. (1985). Autism and the Fragile X Syndrome. Paper presented at the 6th Annual

Conference entitled Model Programs and New Technologies for People with Disabilities, Young Adult Institute, United Engineering Center, New York, April.

25. Cohen, I.L. (1985). Behavioral features of the Fragile X Syndrome. Paper presented at a

symposium entitled Behavioral and genetic features of the Fragile X Syndrome at the 110th Annual Meeting of the American Association on Mental Deficiency, Denver, May.

26. Cohen, I.L. (1985). Fragile(X) and autism: A preliminary analysis of behavioral characteristics.

Poster presented at the Annual Meeting of the American Psychological Association, Los Angeles, August.

27. Cohen, I.L., Fisch, G.S., Wolf-Schein, E.G., Friedman, E., Jenkins, E.C. & Brown, W.T. (1985).

Fragile(X) and autism: A preliminary analysis of behavioral characteristics. Poster presented at the 36th Annual Meeting of the American Society of Human Genetics, Salt Lake City, October.

-1987-

28. Cohen, I.L. (1987). Recent findings on autism and the Fragile X Syndrome: The behavioral

connection. Paper presented at the Second Annual Conference on Autism for Parents and Professionals, Association in Manhattan for Autistic Children, New York, May.

29. Cohen, I.L., Fisch, G.S., Wolf, E.G., Jenkins, E.C. & Brown, W.T. (1987). Infantile autism and

the Fragile X Syndrome. Invited presentation. National Society for Children and Adults with Autism, Detroit, July.

- 19 -

30. Cohen, I.L. (1987). Autism and Fragile X. Invited presentation. Bela Schick Seminar on

Recent Advances in Pediatrics. The Brookdale Hospital Medical Center, Brooklyn, November.

-1988-

31. Cohen, I.L. (1988). Autism and the Fragile X Syndrome. Pediatric Grand Rounds. Morristown

Memorial Hospital, Morristown, NJ, March. 32. Cohen, I.L. (1988). Behavioral phenotype of the Fragile X Syndrome. Paper presented at a

symposium on differential diagnosis at the 113th Annual Meeting of the American Association on Mental Deficiency, Washington, May.

33. Cohen, I.L. (1988). Parent-child dyadic social gaze patterns in fragile X, autistic, Down

Syndrome and non-handicapped males. Paper presented at the 8th Annual Conference of the International Association for the Scientific Study of Mental Deficiency, Dublin, Ireland, August.

34. Cohen, I.L. (1988). Social gaze, social avoidance and repetitive behavior in fragile X males: A

controlled study. Paper presented at the American Association of University Affiliated Programs 1988 Annual Meeting, Denver, October.

-1989-

35. Cohen, I.L. (1989). A review of the association of autism and fragile X. Invited presentation.

1989 Fragile X Conference, Denver, April. 36. Cohen, I.L. (1989). Screening for fragile X in individuals with mental retardation and autism.

Invited presentation. 1989 Fragile X Conference, Denver, April. 37. Cohen, I.L. (1989). On the association between infantile autism and the fragile X syndrome:

prevalence, screening criteria and behavioral phenotype. Paper presented at the Fourth International Workshop on the Fragile X Syndrome and X-Linked Mental Retardation, Arden House Conference Center, Harriman, NY, July.

38. Cohen, I.L. (1989). The Fragile X Syndrome. Invited presentation. Third Annual Training

Conference for Psychologists in State Service, Queens, NY, September. 39. Cohen, I.L. (1989). Autism. Invited presentation. Third Annual Training Conference for

Psychologists in State Service, Queens, NY, September.

-1990-

40. Cohen, I.L. (1990). Panel Discussant on The Fragile X Syndrome, Research Scientist Development Awardee Conference, National Institute of Mental Health, Chevy Chase, MD, June.

- 20 -

-1991-

41. Cohen, I.L. (1991). Effects of long-acting propranolol on agonistic and stereotyped behavior in

an autistic male with fragile X syndrome: a double-blind, placebo controlled study. 1991 Gatlinburg Conference, Key Biscayne, FL, May.

42. Cohen, I.L. (1991). Effects of long-acting propranolol on agonistic and stereotyped behavior in

an autistic male with fragile X syndrome: a double-blind, placebo controlled study. Poster presented at the Congress of X-Linked Mental Retardation 5, Bischenberg, Obernai, France, August.

43. Cohen, I.L. (1991). Autism and Fragile X Syndrome. Invited presentation. Manhattan Chapter,

Autism Society of America, New York, November.

-1992-

44. Cohen, I.L. (1992). Naltrexone and Self-Injury: Methodological Issues. Invited presentation. Learning Processes Colloquium, Queens College, C.U.N.Y., Queens, March.

45. Cohen, I.L. (1992). Diagnosing Autism in Fragile X Syndrome: Is There a Better Way?. Invited

Presentation. Kennedy Krieger Institute, John Hopkins University, Baltimore, April. 46. Cohen, I.L. (1992). The Behavioral Phenotype and the Association with Autism. Invited

presentation. Third International Fragile X Conference, Snowmass Resort, CO, June. 47. Cohen, I.L. (1992). Eye Contact in Fragile X Males. Invited Paper Presented at a Workshop

Entitled The Behavioral Phenotype. Third International Fragile X Conference, Snowmass Resort, CO, June.

48. Cohen, I.L., Dobkin, C., Ding, X.-H., & Brown, W.T. (1992). Autism in Fragile X Families May

Be Associated with Mosaicism of the Fragile X Gene, FMR-1. Poster presented at the Third International Fragile X Conference, Snowmass Resort, CO, June.

49. Cohen, I.L. (1992). Behavioral Aspects of the Fragile X Male. Invited Presentation. The First

Northeast Fragile X Conference for Parents and Professionals, October. 50. Cohen, I.L. (1992). Managing Behavioral Difficulties in Persons With Fragile X Male. Invited

Presentation. The First Northeast Fragile X Conference for Parents and Professionals, October.

- 21 -

-1993-

51. Cohen, I.L. (1993). Fragile X and Autism. Invited presentation. Autism Society of America,

Queens County Chapter, January. 52. Cohen, I.L., Sudhalter, V., Keogh, M. & Landon-Jimenez, D. (1993). A Neural Network

Approach to the Classification of Autism. Poster Presentation. The 26th Annual Gatlinburg Conference on Research and Theory in Mental Retardation and Developmental Disabilities, Gatlinburg, TN, March.

53. Cohen, I.L., Sudhalter, V., Keogh, M. & Landon-Jimenez, D. (1993). A Neural Network

Approach to the Classification of Autism. Poster Presentation. Fifth Annual Symposium on Research on Developmental Disabilities, Queens College, C.U.N.Y., March.

54. Cohen, I.L., Chair (1993 - Multispecialty Symposium) Neural Networks in Clinical Psychology:

Modeling of Behavior Disorders, Diagnosis, and Sub-Typing. With Daniel S. Levine, Samuel Leven, Norman Bray and Ryan Tweeney. American Psychological Society, Chicago, IL, June.

55. Cohen, I.L. (1993). Etiology and Differential Diagnosis of Autism and Pervasive Developmental

Disorders. Invited Presentation. Autism Advocacy and Outreach Group, Staten Island, April. 56. Cohen, I.L. (1993). The Diagnosis of Autism in Fragile X Syndrome: Is There a Better Way?

Grand Rounds Presentation. Stanley S. Lamm Institute for Child Neurology and Developmental Medicine. Long Island College Hospital, Brooklyn, NY, September.

57. Cohen, I.L. (1993). Artificial Neural Network Classification of Behavioral Subtypes of Autism

and Fragile X Syndrome. Invited Presentation. 3rd Consensus Conference on Biological Basis and Clinical Perspectives in Autism. Troina, Italy, October.

58. Cohen, I.L. (1993). The Behavioral Phenotype of Fragile X Syndrome and its Association With

Autism. Invited Presentation. Autism and Neurosciences Conference. Italian Association for Psychosis and Autism Research. Rome, Italy, October.

-1994-

59. Cohen, I.L. (1994). An Artificial Neural Network Analogue of Learning in Autism. Poster

Presentation. Sixth Annual Symposium on Research on Developmental Disabilities, Queens College, C.U.N.Y., March.

60. Cohen, I.L., Sudhalter, V., Landon-Jimenez, D. & Keogh, M. (1994). A Neural Network

Approach to the Classification of Autism. Poster Presentation. World Congress on Neural Networks - San Diego. June 7, 1994.

61. Cohen, I.L. (1994). An Artificial Neural Network Analogue of Learning in Autism. Poster

Presentation. World Congress on Neural Networks - San Diego. June 7, 1994.

- 22 -

62. Cohen, I.L. (1994). Behavior Issues in Fragile X. Invited presentation. Fourth International

Fragile X Conference, Albuquerque, NM. June 10, 1994. 63. Cohen, I.L. (1994). Behavior Aspects of Fragile X Syndrome. Invited presentation. The Second

Northeast Fragile X Conference for Parents and Professionals, November 13-14.

-1995-

64. Cohen, I.L. (1995). Early Intervention for Children with Autism. Invited presentation. Consortium for Medical Education in Developmental Disabilities (C-MEDD) Meeting, January 23.

65. Cohen, I.L. (1995). Diagnosing Autism. Invited presentation. Autism Advocacy and Outreach

Group, Staten Island. March 30. 66. Cohen, I.L. (1995). Fragile X and Autism. Invited presentation. Research and New

Developments Workshop. West Point Army Community Service. Highland Falls, NY. April 6.

67. Cohen, I.L. (1995). Autistic Disorder - A Review. Invited presentation. Upstate Home for

Children and Adults. Oneonta, NY, June 6. 68. Cohen, I.L. (1995). Autistic Disorder - A Review. Invited presentation. Association in

Manhatten for Autistic Children, N.Y., NY., Sept 5. 69. Cohen, I.L. (1995). Diagnosing Autism. Invited presentation. Eden II School, Staten Island,

NY, Sept. 6. 70. Cohen, I.L. (1995). An Artificial Neural Network Analogue of Learning in Autism. Invited

Presentation. 4th Consensus Conference on Biological Basis and Clinical Perspectives in Autism. Troina, Italy, October.

71. Cohen, I.L. (1995). An Artificial Neural Network Analogue of Learning in Autism. Invited

Presentation. Autismo: Handicap Grave Il Problema “Dei Gravi”. Italian Association for Psychosis and Autism Research. Rome, Italy, October.

72. Cohen, I.L. (1995). Outcomes in Intensive Applied Behavioral Interventions in PDD and Autism.

Invited Presentation. Controversy in Pervasive Developmental Disorder and Autism: The State of Early Intervention. Albany Medical College, Albany, NY, December.

73. Cohen, I.L. (1995). Fragile X Syndrome in Males. Invited Presentation. Conference on Learning

and Developmental Disabilities. Institute for Child Development. SUNY at Binghamton, Binghamton, NY, December.

- 23 -

-1996-

74. Cohen, I.L. (1996). Autism. Invited Presentation. Association in Manhattan for Autistic Children.

March. 75. Cohen, I.L. (1996). Neural Network Analysis of Learning in Autism. Paper presented at

conference entitled Autism: Biological, Behavioral and Cognitive Issues in Intervention. Staten Island, NY June.

76. Cohen, I.L. (1996). Neural Network Classification of Autism and other Pervasive

Developmental Disorders. Invited paper presented at symposium entitled: Fuzzy Sets and Neural Networks: New Methods for Applied Psychology. 104th Annual Meeting of the American Psychological Association, Toronto, August.

-1997-

77. Cohen, I.L. (1997). Autistic Disorder. Invited presentation. Morris County Psychological

Association. Morristown, NJ, May. 78. Cohen, I.L. (1997). A Neural Network Model of Autistic Disorder: Implications for Etiology,

Treatment and the "Broader Phenotype." Invited Paper. International Conference on Mental Retardation: Genes, Brain and Behavior, Staten Island, July.

79. Cohen, I.L. (1997). The Biology of Autism. Invited Paper. New York State Association for

Behavior Analysis Annual Conference. Tarrytown, NY, September. 80. Cohen, I.L. (1997). Infantile Autism. Invited Paper. Annual Lauretta Bender Lecture and

Symposium. The Legacy of Lauretta Bender, M.D.: Current Applications. Queens Children's Psychiatric Center, November.

81. Cohen, I.L. (1997). Autism: Assessment, Diagnosis, Etiology and Treatment. Grand Rounds

Presentation in Psychiatry. St. Lukes/Roosevelt Hospital, Manhattan, November.

-1998- 82. Cohen, I.L. (1998). A Neural Network Analysis of Autism: Implications for Theory and

Treatment. Invited Presentation. The 8th Annual New York State Association for Behavior Analysis Conference, October.

83. Cohen, I.L. (1998). Autism and Depression. Invited Presentation. George A. Jervis Clinic. New

York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, October.

84. Cohen, I.L. (1998). Autism: Diagnostic Issues, Treatment and Computer Models of the

Disorder. Invited Presentation. Neuroscientific Advances: Autism and Effective Behavioral Strategies. Bancroft NeuroHealth, Cherry Hill, NJ, November.

85. Cohen, I.L. (1998). Autism: Diagnostic Issues, Treatment and Computer Models of the

Disorder. Invited Presentation. Neuroscientific Advances: Autism and Effective Behavioral Strategies. Bancroft NeuroHealth, Rockport , ME, November.

- 24 -

-1999-

86. Cohen, I.L. (1999). Dissemination of “Clinical Practice Guideline for Parents and

Professionals: Autism/Pervasive Developmental Disorders, Assessment and Intervention for Young Children (Age 0-3 Years). Albany, NY, March.

87. Cohen, I.L. (1999). Dissemination of “Clinical Practice Guideline for Parents and

Professionals: Autism/Pervasive Developmental Disorders, Assessment and Intervention for Young Children (Age 0-3 Years). Manhattan, May.

88. Cohen, I.L. (1999). Maternal Mood Disorder and Anxiety and the Behavior and Adaptive

Development of Their Preschool-Aged Children with Autism. Invited presentation. 25th Anniversary of the Children’s Units. Institute for Child Development Conference on Learning and Developmental Disabilities. Binghamton University. Binghamton, NY, September.

89. Cohen, I.L. (1999). Autism. Invited presentation. Board of Education District 75

Conference. New York State Institute for Basic Research in Developmental Disabilities, Staten Island, November.

90. Cohen, I.L. (1999). Autism and a Computer Model of the Disorder. Invited presentation.

CSI/IBR Center for Developmental Neurosciences Colloquium on Current Topics in Developmental Disabilities. Staten Island, November.

-2000-

91. Cohen, I.L. (2000). Autism in Developmental Disabilities. Grand Rounds Presentation in

Neurology. State University of New York Health Science Center at Brooklyn, Brooklyn, October.

-2001-

92. Cohen, I.L. (2001). Autism and Applied Behavior Analysis: Issues, Controversies, Evidence-

Based Criteria. Invited presentation. Long Island College Hospital, Brooklyn, May. 93. Cohen, I.L. (2001). Biomedical Findings and Differential Diagnosis in Autism Spectrum

Disorders. Invited presentation. Brooklyn College-CUNY, Brooklyn, May. 94. Cohen, I.L. (2001). A Neural Network Analogue of Autism: Implications for Theory and

Treatment. Paper presented at the Xth European Conference on Developmental Psychology, Uppsala, Sweden, August.

95. Cohen, I.L. (2001). Parental Depression and the Behavior and Development of Preschool-

Aged Children with PDD. Paper presented at the Xth European Conference on Developmental Psychology, Uppsala, Sweden, August.

96. Cohen, I.L. (2001). A Neural Network Analogue of Autism: Implications for Theory and

Treatment. Poster presented at the First Annual International Meeting for Autism Research, San Diego, November.

- 25 -

97. Cohen, I.L. (2001). Parental Depression and the Behavior and Development of Preschool-Aged Children with PDD. Poster presented at the 31st Annual Meeting of the Society for Neuroscience, San Diego, November.

-2002-

98. Cohen, I.L. (2002). Autism: Assessment, Etiology and Predictors of Outcome. Invited

presentation. Experimental Psychology seminar series. Bar-Ilan University, Ramat Gan, Israel, May.

99. Cohen, I.L. (2002). Understanding the Phenotype of Autism. Grand Rounds Presentation in

Neurology. State University of New York Health Science Center at Brooklyn, Brooklyn, October.

100. Cohen, I.L., Liu, X., Schutz, C., White, B.N., Jenkins, E.C., Brown, W.T., and Holden,

J.J.A. (2002). The Monoamine Oxidase A uVNTR Polymorphism Is Associated With Both IQ And Symptom Severity In Young Males With Autism Spectrum Disorder: A Longitudinal Study . Poster presented at the Second Annual International Meeting for Autism Research, Orlando, November.

101. Chauhan, V.P.S., Chauhan, A., Cohen, I., and Sheikh, A.H. (2002). Autism – A

Membrane Lipid Disorder: Alterations in Phosphatidylethanolamine Levels, Fluidity, and Lipid Peroxidation. Poster presented at the Second Annual International Meeting for Autism Research, Orlando, November.

102. Chauhan, A., Chauhan, V.P.S., and Cohen, I. (2002). Reduced Serum Levels of

Ceruloplasmin and Transferrin – Antioxidant Proteins in Autism. Poster presented at the Second Annual International Meeting for Autism Research, Orlando, November.

103. Udcoff, A.M., Ploog, F.M., and Cohen, I. (2002). Using the ADOS-G to Probe for

Expression of Mental States in High-Functioning Children with and Autistic Spectrum Disorder. Poster presented at the Second Annual International Meeting for Autism Research, Orlando, November.

-2003-

104. Cohen, I.L. (2003). Current Research in Autism. Invited Presentation. NYS Institute for

Basic Research in Developmental Disabilities, Staten Island, March. 105. Cohen, I.L. (2003). Advances in Autism Research: What Do the Data Tell Us. Invited

Keynote Presentation at conference entitled Working Together: Systems and Strategies for Improving Outcomes for Individuals with Autism Spectrum Disorders, New York, New York Academy of Medicine, March.

106. Cohen, I.L. (2003). The Diagnostic Work-Up of Autism. Invited Presentation at conference

entitled The Social Brain, Göteborg, Sweden, March. 107. Cohen, I.L. (2003). A Neural Network Analogue of Autism. Poster Presentation at

conference entitled The Social Brain, Göteborg, Sweden, March.

- 26 -

108. Cohen, I.L., Liu, X., Schutz, C., White, B.N., Jenkins, E.C., Brown, W.T., and Holden, J.J.A. (2002). The Monoamine Oxidase A uVNTR Polymorphism Is Associated With Both IQ And Symptom Severity In Young Males With Autism Spectrum Disorder: A Longitudinal Study. Poster presented at the Biennial Meeting of the Society for Research in Child Development, Tampa, FL, April.

109. Cohen, I.L. (2003). Assessment, Medical Findings, Differential Diagnosis, and Treatment.

Invited presentation at conference entitled The Puzzle of Autism, Larissa, Greece, May. 110. Holden, J.J.A., Liu, X., Schutz, C., White, B.N., Jenkins, E.C., Brown, W.T., and Cohen, I.L.

(2003). A Functional Polymorphism in the MAOA Gene is Associated with Severity of Autism. Poster presented at the XIth World Congress of Psychiatric Genetics, Quebec, October.

111. Cohen, I.L., Liu, X., Schutz, C., White, B.N., Jenkins, E.C., Brown, W.T., and Holden, J.J.A.

(2003). Association of Autism Severity with an MAOA Functional Polymorphism. Neurogenomics of mice and men, New Orleans, November.

-2004-

112. Cohen, I.L. (2004). Autism Research at IBR: The PDDBI and the Prevalence of Autism on

Staten Island. Invited presentation. Premier Health Care, May 5, New York. 113. Cohen, I.L. (2004). Reliability and Validity of the PDD Behavior Inventory. International

Meeting for Autism Research, May 8, Sacramento. 114. Cohen, I.L. (2004). Autism: Assessment, Etiology, and Associated Medical Conditions, and

Epidemiology. Keynote address. New York State Association for Behavior Analysis, October 14, Saratoga Springs.

115. Cohen, I.L. (2004). Reliability and Validity of the PDD Behavior Inventory. Invited Workshop.

New York State Association for Behavior Analysis, October 15, Saratoga Springs.

-2005- 116. Cohen, I.L. (2005). Maternal Recurrent Mood Disorders and High-Functioning Autism.

International Meeting for Autism Research, May 7, Boston 117. Chauhan, V.P.S., Chauhan, A., Cohen, I., and Sheikh, A.M. (2005). Autism – A Membrane

Lipid Disorder: Alterations in Phosphatidylethanolamine Levels, Fluidity, and Lipid Peroxidation. International Meeting for Autism Research, May 7, Boston

118. Chauhan, A., Chauhan, V.P.S., and Cohen, I. (2005). Reduced Serum Levels of

Ceruloplasmin and Transferrin – Antioxidant Proteins in Autism. International Meeting for Autism Research, May 7, Boston.

119. Cohen, I.L. (2005). Maternal Recurrent Mood Disorders and High-Functioning Autism.

Invited presentation. Gonda Brain Research Center, Bar-Ilan University, June 25, Ramat Gan, Israel

- 27 -